Reuters logo
BRIEF-RaQualia Pharma to fully acquire TMRC via stock swap
December 26, 2016 / 6:35 AM / 9 months ago

BRIEF-RaQualia Pharma to fully acquire TMRC via stock swap

Dec 26 (Reuters) - RaQualia Pharma Inc :

* Says RaQualia Pharma enters into agreement to fully acquire TMRC Co Ltd which is engaged in anticarcinogen related business, through stock swap, with effective date on Feb. 3, 2017

* One share of TMRC’s stock will be exchanged with 90 shares of co’s stock

* 479,250 shares of co’s stock will be exchanged

Source text in Japanese: goo.gl/aXc5mK

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below